Full text is available at the source.
Abstract
Research on the risk of post-acute sequelae of coronavirus disease 2019 (COVID-19) in individuals with depressive disorder is limited.
- Individuals with depressive disorder may encounter additional challenges in accessing healthcare.
- The risk of experiencing long-term effects after COVID-19, known as PASC, is not well-studied in this population.
- Understanding the intersection of depressive disorder and COVID-19 recovery is essential for effective healthcare planning.
Simplified